Article Information
History
- March 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Michal Sadowski1,†,
- Mike Thompson1,
- Joel Mefford2,
- Tanushree Haldar3,4,
- Akinyemi Oni-Orisan3,4,
- Richard Border2,5,6,
- Ali Pazokitoroudi5,
- Julien F. Ayroles7,8,
- Sriram Sankararaman1,5,6,9,
- Andy Dahl10,* and
- Noah Zaitlen1,2,6,9,*,†
- 1Bioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, USA
- 2Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA
- 3Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA
- 4Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA, USA
- 5Department of Computer Science, University of California Los Angeles, Los Angeles, CA, USA
- 6Department of Computational Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
- 7Department of Ecology and Evolution, Princeton University, Princeton, NJ, USA
- 8Lewis Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA
- 9Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
- 10Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA
- ↵†Corresponding authors: Noah Zaitlen (nzaitlen{at}ucla.edu), Michal Sadowski (michalsadowski{at}ucla.edu)
↵* Contributed equally to this article
Posted March 30, 2024.
Characterizing the genetic architecture of drug response using gene-context interaction methods
